By the end of this decade, the global inhalation drug delivery devices market is expected to top $18 billion USD. That is why you cannot afford to miss Pharma Ed’s Inhalation Drug Delivery Forum 2023. This two-day conference will bring together specialists from the medical, pharmacological, and health care industries looking to learn the latest technical and engineering advances in respiratory delivery systems for large and small molecule drugs and biologics.

The growing interest in alternative routes of drug and vaccine administration has experts predicting that the market for microneedle drug delivery systems could exceed $30 billion by 2025. The industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems. That is why you cannot afford to miss this two-day intensive conference. Pharma Ed’s Microneedle & Transdermal Drug Delivery Forum 2023 brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

Regulators in North America and Europe are requiring stricter standards for environmental monitoring systems, facility cleaning and disinfectant qualification, aseptic cleanroom operations, filtration, sterilization, and aseptic process simulation (or media fill). This two-day summit features expert insight into the robust aseptic processing requirements facing the industry. Pharma Ed’s Aseptic Processing Summit features comprehensive coverage on the implementation and management of the latest knowledge in aseptic, barrier, containment, and aseptic best practice technologies.

This two-day conference will examine the safety, quality, and regulatory issues involved in a wide array of contexts central to the pharmaceutical and biotech industries, including drug packaging and delivery components, single-use systems, medical devices, and parenteral drug products. We will focus closely on the keys to satisfying recent revisions to several applicable USP chapters, FDA guidances & other international regulatory requirements for best practices in materials and chemistry characterization for drugs, biologics, delivery systems, and primary & secondary packaging.

Projected to hit $8 billion by the end of 2024 in the US alone, the market for pre-filled syringes and autoinjectors continues to expand at an impressive rate. Numerous advantages such as ease of administration, enhanced safety, reduced risk of contamination, and accuracy of dosing, have made PFS & autoinjectors attractive over other delivery systems. Growth in the biologics market, rising preference for self-administrations which use pre-filled syringes, pen injectors, and autoinjectors, are propelling the growth of the market. This is why you cannot afford to miss Pharma Ed Resources’ Pre-filled Syringes & Autoinjectors Forum. This two-day summit brings together thought-leaders and key decision makers to illuminate current and future trends in this vital market.